Clinical Trial Update: Early Administration of L-carnitine in Hemodialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating early administration of L-carnitine in hemodialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperthyroidism

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Complication of Hemodialysis, Hyperthyroidism Treated or Under Control | Phase 3 | Status: COMPLETED